Literature DB >> 12459342

Probiotics and health: new facts and ideas.

Philippe Marteau1, Philippe Seksik, Raymond Jian.   

Abstract

Many trials on probiotics are now published that use established methods to demonstrate their clinical efficacy. Convincing progress has been made in the field of inflammatory bowel disease and allergy prevention in infants. Experimental studies show clear differences (and even sometimes opposite effects) between apparently closely related probiotics and suggest new mechanisms for the observed effects, such as immunostimulation by bacterial DNA and interaction with Toll-like receptors and dendritic cells in the gastrointestinal tract.

Entities:  

Mesh:

Year:  2002        PMID: 12459342     DOI: 10.1016/s0958-1669(02)00368-3

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  4 in total

1.  Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis.

Authors:  B Sheil; J McCarthy; L O'Mahony; M W Bennett; P Ryan; J J Fitzgibbon; B Kiely; J K Collins; F Shanahan
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  NOD dendritic cells stimulated with Lactobacilli preferentially produce IL-10 versus IL-12 and decrease diabetes incidence.

Authors:  Jean N Manirarora; Sarah A Parnell; Yoon-Hyeon Hu; Michele M Kosiewicz; Pascale Alard
Journal:  Clin Dev Immunol       Date:  2011-06-12

3.  New insights into the possible role of bacteriophages in host defense and disease.

Authors:  Andrzej Gorski; Krystyna Dabrowska; Kinga Switala-Jeleń; Maria Nowaczyk; Beata Weber-Dabrowska; Janusz Boratynski; Joanna Wietrzyk; Adam Opolski
Journal:  Med Immunol       Date:  2003-02-14

4.  Assessment of the Safety of Lactobacillus casei IMV B-7280 Probiotic Strain on a Mouse Model.

Authors:  Lazarenko L M; Babenko L P; Gichka S G; Sakhno L O; Demchenko O M; Bubnov R V; Sichel L M; Spivak M Ya
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04-20       Impact factor: 4.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.